Simcere Pharmaceutical Group Limited (HKG:2096)

HKG:2096 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	31,071	17,653	17,611	30,914	23,628	23,347
Market Cap Growth	76.38%	0.24%	-43.03%	30.83%	1.20%	-
Enterprise Value	29,485	15,639	16,205	29,371	23,209	26,834
Last Close Price	11.97	6.98	6.42	10.84	8.23	8.09
PE Ratio	30.52	22.63	22.37	29.38	12.77	29.36
Forward PE	21.72	14.35	12.11	29.04	26.63	18.00
PS Ratio	3.99	2.50	2.42	4.32	3.85	4.36
PB Ratio	3.92	2.35	2.21	3.83	2.98	3.68
P/TBV Ratio	4.97	2.81	2.51	4.16	3.10	3.89
P/FCF Ratio	27.32	16.04	-	27.04	-	-
P/OCF Ratio	20.33	11.93	105.83	20.19	-	203.24
PEG Ratio	-	1.12	1.12	1.12	1.12	-
EV/Sales Ratio	3.79	2.22	2.23	4.11	3.78	5.01
EV/EBITDA Ratio	17.21	10.83	15.90	31.86	44.76	29.79
EV/EBIT Ratio	21.25	12.97	20.69	42.85	81.03	37.66
EV/FCF Ratio	25.92	14.21	-	25.69	-	-
Debt / Equity Ratio	0.17	0.17	0.20	0.21	0.25	0.62
Debt / EBITDA Ratio	0.79	0.84	1.43	1.72	3.50	4.10
Debt / FCF Ratio	1.19	1.17	-	1.49	-	-
Asset Turnover	0.58	0.59	0.61	0.60	0.47	0.51
Inventory Turnover	1.91	1.80	2.84	4.01	3.59	2.94
Quick Ratio	1.53	1.73	1.76	1.69	1.51	1.48
Current Ratio	1.73	2.00	2.10	1.84	1.63	1.85
Return on Equity (ROE)	12.45%	10.26%	9.94%	13.62%	25.41%	19.49%
Return on Assets (ROA)	6.50%	6.33%	4.11%	3.62%	1.38%	4.23%
Return on Capital (ROIC)	9.55%	8.37%	5.13%	4.52%	1.74%	5.74%
Return on Capital Employed (ROCE)	13.90%	12.90%	8.70%	7.80%	3.30%	8.10%
Earnings Yield	3.10%	4.42%	4.47%	3.40%	7.83%	3.41%
FCF Yield	3.66%	6.23%	-2.08%	3.70%	-2.14%	-1.30%
Dividend Yield	1.49%	2.44%	2.74%	1.67%	2.24%	2.20%
Payout Ratio	45.61%	54.76%	58.65%	42.04%	25.96%	-
Buyback Yield / Dilution	4.18%	3.40%	0.45%	-0.34%	-9.14%	-2.03%
Total Shareholder Return	5.67%	5.83%	3.19%	1.32%	-6.91%	0.18%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.